Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(25%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_3
1
13%
Ph phase_2
1
13%
Ph not_applicable
5
63%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Other(2)

Detailed Status

Completed4
Active, not recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
N/A5 (71.4%)

Trials by Status

active_not_recruiting225%
completed450%
unknown225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8